News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
538,063 Results
Type
Article (31148)
Company Profile (128)
Press Release (506785)
Multimedia
Podcasts (79)
Webinars (15)
Section
Business (147030)
Career Advice (939)
Deals (26278)
Drug Delivery (102)
Drug Development (49792)
Employer Resources (96)
FDA (12437)
Job Trends (11808)
News (242133)
Policy (24900)
Tag
2027 BioCapital Elite (1)
2027 BioMidwest Elite (2)
2027 BioMidwest Standard (1)
2027 Bio NC Standard (2)
2027 Biotech Bay Elite (1)
2027 Biotech Bay Standard (1)
2027 Biotech Beach Elite (2)
2027 Genetown Elite (4)
2027 Genetown Standard (2)
2027 Pharm Country Elite (2)
2027 Pharm Country Standard (5)
Academia (2229)
Academic (2)
Accelerated approval (38)
Adcomms (19)
Allergies (125)
Alliances (35900)
ALS (132)
Alzheimer's disease (1317)
Antibody-drug conjugate (ADC) (260)
Approvals (12891)
Artificial intelligence (534)
Autoimmune disease (206)
Automation (36)
Bankruptcy (210)
Best Places to Work (10001)
BIOSECURE Act (8)
Biosimilars (201)
Biotechnology (74)
Bladder cancer (139)
Brain cancer (52)
Breast cancer (515)
Cancer (3782)
Cardiovascular disease (377)
Career advice (842)
Career pathing (19)
CAR-T (196)
CDC (67)
Celiac Disease (1)
Cell therapy (560)
Cervical cancer (41)
Clinical research (44214)
Collaboration (1519)
Company closure (1)
Compensation (609)
Complete response letters (42)
COVID-19 (2439)
CRISPR (75)
C-suite (927)
Cystic fibrosis (110)
Data (5728)
Decentralized trials (3)
Denatured (24)
Depression (143)
Dermatology (71)
Diabetes (435)
Diagnostics (6028)
Digital health (60)
Diversity (10)
Diversity, equity & inclusion (29)
Drug discovery (215)
Drug pricing (181)
Drug shortages (14)
Duchenne muscular dystrophy (181)
Earnings (63373)
Editorial (52)
Employer branding (13)
Employer resources (90)
Events (95532)
Executive appointments (938)
FDA (15362)
Fibrodysplasia Ossificans Progressiva (7)
Friedreich's ataxia (13)
Frontotemporal dementia (27)
Funding (1412)
Gene editing (137)
Generative AI (49)
Gene therapy (401)
GLP-1 (719)
Government (4587)
Grass and pollen (6)
Guidances (363)
Healthcare (17175)
HIV (75)
Huntington's disease (27)
IgA nephropathy (73)
Immunology and inflammation (143)
Immuno-oncology (56)
Indications (149)
Infectious disease (2771)
Inflammatory bowel disease (160)
Inflation Reduction Act (16)
Influenza (130)
Intellectual property (156)
Interviews (115)
IPO (12208)
IRA (41)
Job creations (2203)
Job search strategy (743)
JPM (63)
Kidney cancer (16)
Labor market (58)
Layoffs (297)
Leadership (18)
Legal (5590)
Liver cancer (73)
Longevity (25)
Lung cancer (451)
Lymphoma (279)
Machine learning (36)
Management (34)
Manufacturing (656)
MASH (143)
Medical device (11149)
Medtech (11267)
Mergers & acquisitions (15095)
Metabolic disorders (1106)
mRNA (168)
Multiple sclerosis (140)
NASH (11)
Neurodegenerative disease (284)
Neuropsychiatric disorders (79)
Neuroscience (2428)
Neurotech (1)
NextGen: Class of 2026 (5566)
Non-profit (4139)
Now hiring (20)
Obesity (502)
Opinion (198)
Ovarian cancer (128)
Pain (170)
Pancreatic cancer (181)
Parkinson's disease (252)
Partnered (22)
Patents (302)
Patient recruitment (465)
Peanut (35)
People (46448)
Pharmaceutical (34)
Pharmacy benefit managers (33)
Phase 1 (13815)
Phase 2 (18242)
Phase 3 (15318)
Pipeline (7102)
Policy (279)
Postmarket research (1830)
Preclinical (4894)
Press Release (72)
Prostate cancer (219)
Psychedelics (45)
Radiopharmaceuticals (254)
Rare diseases (770)
Real estate (3984)
Recruiting (40)
Regulatory (18896)
Reports (32)
Research institute (2094)
Resumes & cover letters (107)
Rett syndrome (32)
RNA editing (14)
RSV (77)
Schizophrenia (144)
Series A (218)
Series B (173)
Service/supplier (5)
Sickle cell disease (90)
Special edition (15)
Spinal muscular atrophy (109)
Sponsored (35)
Startups (2608)
State (1)
Stomach cancer (6)
Supply chain (89)
Tariffs (51)
The Weekly (54)
Vaccines (979)
Venture capital (83)
Weight loss (301)
Women's health (126)
Worklife (8)
Date
Today (29)
Last 7 days (491)
Last 30 days (2558)
Last 365 days (22869)
2026 (10457)
2025 (23029)
2024 (26757)
2023 (30372)
2022 (40616)
2021 (44798)
2020 (44464)
2019 (38381)
2018 (28932)
2017 (23118)
2016 (23386)
2015 (27714)
2014 (21514)
2013 (17359)
2012 (18501)
2011 (19208)
2010 (17671)
Location
Africa (634)
Alabama (46)
Alaska (7)
Arizona (252)
Arkansas (14)
Asia (28607)
Australia (4820)
California (9617)
Canada (3379)
China (876)
Colorado (429)
Connecticut (460)
Delaware (269)
Europe (64208)
Florida (1513)
Georgia (339)
Hawaii (2)
Idaho (56)
Illinois (847)
India (87)
Indiana (587)
Iowa (19)
Japan (443)
Kansas (110)
Kentucky (40)
Louisiana (43)
Maine (86)
Maryland (1273)
Massachusetts (7093)
Michigan (274)
Minnesota (576)
Mississippi (4)
Missouri (143)
Montana (24)
Nebraska (23)
Nevada (124)
New Hampshire (73)
New Jersey (3023)
New Mexico (17)
New York (2793)
North Carolina (1384)
North Dakota (7)
Northern California (4949)
Ohio (318)
Oklahoma (19)
Oregon (31)
Pennsylvania (2079)
Puerto Rico (16)
Rhode Island (35)
South America (835)
South Carolina (44)
South Dakota (2)
Southern California (3750)
Tennessee (186)
Texas (1479)
United States (36082)
Utah (367)
Virginia (235)
Washington D.C. (67)
Washington State (863)
West Virginia (3)
Wisconsin (133)
Wyoming (2)
538,063 Results for "medx health corp".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
MedX Announces $2,700,000 Initial Closing of Non-Brokered Private Placement of Series IV Convertible Loan Notes
February 27, 2026
·
4 min read
Cell MedX Corp. Announces Resignation of Director
Cell MedX Corp. (OTC Pink: CMXC) (“Cell MedX”, or the “Company”) a biotech company focusing on the discovery, development and commercialization of therapeutic
February 29, 2024
·
2 min read
Cell MedX Corp. Closes Private Placement Financing
Cell MedX Corp. (OTC Pink: CMXC) (“Cell MedX”, or the “Company”) a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products
March 19, 2024
·
3 min read
MedX Health Corp. Announces Conversion of $2.965 Million of Secured Convertible Debentures
MedX Health Corp. is pleased to announce that, effective November 17, 2023, $2,965,000 of Secured Convertible Debentures were fully redeemed pursuant to exercise of the Conversion Rights by the Holders, resulting issuance of 59,300,000 common shares and 59,300,000 share purchase warrants exercisable at $0.20 until December 31, 2027.
November 21, 2023
·
2 min read
Business
Cell MedX Corp. Announces New CEO and Directors and Debt Settlement
Cell MedX Corp. (OTC Pink: CMXC) (“Cell MedX” or the “Company”), a biotech company focusing on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, announces that Mr. Dwayne Yaretz
December 19, 2023
·
5 min read
Press Releases
Illumisoft Lighting Corp. Provides Corporate Update Following Commencement of Trading
May 5, 2026
·
14 min read
Press Releases
Optimi Health Launches Ibogaine Initiative as U.S. Executive Order Signals Pathway for Psychedelic Drug Products
The Company’s Health Canada-licensed GMP psychedelic manufacturing platform ready to serve emerging demand for ibogaine, a naturally occurring alkaloid under investigation for opioid use disorder, PTSD, and traumatic brain injury
April 20, 2026
·
6 min read
Sponsored
Turn health data into impact: Browns University’s online master in biostatistics & health data science
Trained biostatisticians play a central role in clinical science and public health. Brown’s online master’s in biostatistics (health data science concentration), prepares you with a strong foundation in biostatistical and data science methods combined with rigorous training in applied skills to make critical data-driven decisions and meet the growing demand for leaders in this industry – on your schedule
April 27, 2026
·
3 min read
Press Releases
Zenith Capital Corp. Amends Promissory Notes
May 12, 2026
·
6 min read
Cell MedX Corp. Announces Full Revocation of British Columbia Cease Trade Order
Cell MedX Corp. (“Cell MedX” or the “Company”) (OTC Pink: CMXC) announces that on November 22, 2023, the British Columbia Securities Commission
November 28, 2023
·
4 min read
1 of 53,807
Next